Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression

被引：0
|
作者：
Kun Wang
Xiaoyong Dai
Albert Yu
Chunyan Feng
Kewei Liu
Laiqiang Huang
机构：
[1] Shenzhen Key Laboratory of Gene and Antibody Therapy,
[2] Center for Biotechnology and Biomedicine,undefined
[3] State Key Laboratory of Chemical Oncogenomics,undefined
[4] State Key Laboratory of Health Sciences and Technology,undefined
[5] Precision Medicine and Healthcare Research Center,undefined
[6] Tsinghua-Berkeley Shenzhen Institute (TBSI),undefined
[7] Institute of Biopharmaceutical and Health Engineering,undefined
[8] Shenzhen International Graduate School,undefined
[9] Tsinghua University,undefined
[10] School of Life Sciences,undefined
[11] Tsinghua University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 41卷
关键词：
P-PROTACs; FOXM1; Liver cancer; Breast cancer; GLUT1; PD-L1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription
    Wang, Yu
    Yun, Yuyu
    Wu, Bo
    Wen, Li
    Wen, Mingling
    Yang, Huiling
    Zhao, Lisheng
    Liu, Wenchao
    Huang, Suyun
    Wen, Ning
    Li, Yu
    ONCOTARGET, 2016, 7 (30) : 47985 - 47997
  • [42] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [43] Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
    Zaslavsky, Alexander B.
    Adams, M. P.
    Cao, X.
    Maj, T.
    Choi, J. E.
    Stangl-Kremser, J.
    Patel, S.
    Putelo, A.
    Lee, S. K.
    Nallandhighal, S.
    Kasputis, A.
    Alva, A.
    Lew, M.
    Qin, A.
    Mehra, R.
    Morgan, T. M.
    Salami, S. S.
    Reichert, Z.
    Udager, A.
    Zou, W.
    Palapattu, Ganesh S.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
    Imai, Yushi
    Chiba, Tetsuhiro
    Kondo, Takayuki
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Ao, Junjie
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kato, Jun
    Kotani, Ai
    Matsubara, Hisahiro
    Kato, Naoya
    ONCOLOGY LETTERS, 2020, 20 (03) : 2161 - 2168
  • [45] Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
    Alexander B. Zaslavsky
    M. P. Adams
    X. Cao
    T. Maj
    J. E. Choi
    J. Stangl-Kremser
    S. Patel
    A. Putelo
    S. K. Lee
    S. Nallandhighal
    A. Kasputis
    A. Alva
    M. Lew
    A. Qin
    R. Mehra
    T. M. Morgan
    S. S. Salami
    Z. Reichert
    A. Udager
    W. Zou
    Ganesh S. Palapattu
    Scientific Reports, 10
  • [46] A new energy restriction mimetic decreases survival and FOXM1 expression in pancreatic cancer cells
    Scolaro, Laura
    Lanza-Jacoby, Susan
    CANCER RESEARCH, 2017, 77
  • [47] GLUT4 but not GLUT1 expression decreases early in the development of feline obesity
    Brennan, CL
    Hoenig, M
    Ferguson, DC
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2004, 26 (04) : 291 - 301
  • [48] SIGNIFICANCE OF PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER BIOLOGY
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Giridhar, S.
    Wenzel, S.
    Sprung, S.
    Lax, S.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 555 - 555
  • [49] Blocking of the PD-1/PD-L1 interaction by an affinity peptide for cancer immunotherapy
    Luo, H.
    Li, X.
    Zhu, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1782 - 1782
  • [50] PD-L1 and PD1 Expression in Lymphomas
    Gatalica, Zoran
    Bilalovic, Nurija
    Vranic, Semir
    Arguello, David
    Reddy, Sandeep
    Ghosh, Nilanjan
    BLOOD, 2015, 126 (23)
12345